1989 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Denosumab in early breast cancer: negative data and a call to action

Perrone, F. & Gravina, A., Jan 2020, In : The Lancet Oncology. 21, 1, p. 5-6 2 p.

Research output: Contribution to journalComment/debate

Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Lambertini, M., Blondeaux, E., Perrone, F. & Del Mastro, L., 2020, In : Journal of Clinical Oncology. p. JCO1902242

Research output: Contribution to journalArticle

Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer: The PACER Trial

Piccirillo, M. C., Avallone, A., Carlomagno, C., Maiello, E., Rosati, G., Alabiso, O., Nasti, G., De Placido, S., Latiano, T. P., Bilancia, D., Ottaiano, A., De Stefano, A., Romano, C., Silvestro, L., Nappi, A., Cassata, A., Giordano, P., Iaffaioli, R. V., Normanno, N., Perrone, F. & 1 others, Daniele, B., 2020, (Accepted/In press) In : Clinical Colorectal Cancer.

Research output: Contribution to journalArticle

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018

Reale, M. L., De Luca, E., Lombardi, P., Marandino, L., Zichi, C., Pignataro, D., Ghisoni, E., Di Stefano, R. F., Mariniello, A., Trevisi, E., Leone, G., Muratori, L., La Salvia, A., Sonetto, C., Bironzo, P., Aglietta, M., Novello, S., Scagliotti, G. V., Perrone, F. & Di Maio, M., Jan 2020, In : Lung Cancer. 139, p. 47-54 8 p.

Research output: Contribution to journalArticle

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018

Lombardi, P., Marandino, L., De Luca, E., Zichi, C., Reale, M. L., Pignataro, D., Di Stefano, R. F., Ghisoni, E., Mariniello, A., Trevisi, E., Leone, G., Muratori, L., La Salvia, A., Sonetto, C., Leone, F., Aglietta, M., Novello, S., Scagliotti, G. V., Perrone, F. & Di Maio, M., Feb 2020, In : Critical Reviews in Oncology/Hematology. 146, 102877.

Research output: Contribution to journalReview article

Real-World Evidence in Oncology: Opportunities and Limitations

Di Maio, M., Perrone, F. & Conte, P., 2020, In : Oncologist.

Research output: Contribution to journalComment/debate

The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology Meetings

Di Maio, M., Audisio, M., Cardone, C., De Luca, E., Gargiulo, P., Zichi, C. & Perrone, F., 2020, In : JAMA oncology.

Research output: Contribution to journalLetter

2019

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., Sep 1 2019, In : European Journal of Cancer. 118, p. 178-186 9 p.

Research output: Contribution to journalArticle

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., 2019, In : European Journal of Cancer.

Research output: Contribution to journalArticle

Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy

Trotta, F., Mayer, F., Barone-Adesi, F., Esposito, I., Punreddy, R., Da Cas, R., Traversa, G., Perrone, F., Martini, N., Gyawali, B. & Addis, A., Dec 10 2019, In : BMJ Open. 9, 12, p. e033728

Research output: Contribution to journalArticle

Open Access

Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy

Trotta, F., Mayer, F., Barone-Adesi, F., Esposito, I., Punreddy, R., Da Cas, R., Traversa, G., Perrone, F., Martini, N., Gyawali, B. & Addis, A., Dec 10 2019, In : BMJ Open. 9, 12, p. e033728

Research output: Contribution to journalArticle

Assessing financial toxicity in patients with cancer: Moving away from a one-size-fits-all approach

Perrone, F., Di Maio, M., Efficace, F., Gallo, C., Giannarelli, D., Montesarchio, V. & Riva, S., Aug 1 2019, In : Journal of Oncology Practice. 15, 8, p. 460-461 2 p.

Research output: Contribution to journalLetter

Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: A protocol

Riva, S., Bryce, J., De Lorenzo, F., Del Campo, L., Di Maio, M., Efficace, F., Frontini, L., Giannarelli, D., Gitto, L., Iannelli, E., Jommi, C., Montesarchio, V., Traclò, F., Vaccaro, C. M., Gallo, C. & Perrone, F., Sep 1 2019, In : BMJ Open. 9, 9, e031485.

Research output: Contribution to journalArticle

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., Jul 2019, In : Lung Cancer. 133, p. 62-68 7 p.

Research output: Contribution to journalArticle

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., Jul 1 2019, In : Lung Cancer. 133, p. 62-68 7 p.

Research output: Contribution to journalArticle

Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., De Braud, F. & Pietrantonio, F., 2019, In : Journal of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., Jul 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018

Marandino, L., De Luca, E., Zichi, C., Lombardi, P., Reale, M. L., Pignataro, D., Di Stefano, R. F., Ghisoni, E., Mariniello, A., Trevisi, E., Leone, G., Muratori, L., La Salvia, A., Sonetto, C., Buttigliero, C., Tucci, M., Aglietta, M., Novello, S., Scagliotti, G. V., Perrone, F. & 1 others, Di Maio, M., 2019, In : Clinical Genitourinary Cancer.

Research output: Contribution to journalReview article

Real-World Evidence in Oncology: Opportunities and Limitations

Di Maio, M., Perrone, F. & Conte, P., Dec 24 2019, In : The oncologist. p. 1-7 7 p.

Research output: Contribution to journalArticle

The great debate at "melanoma Bridge 2018", Naples, December 1st, 2018

Ascierto, P. A., Bruzzi, P., Eggermont, A., Hamid, O., Tawbi, H. A., Van Akkooi, A., Testori, A., Caracò, C., Puzanov, I. & Perrone, F., May 10 2019, In : Journal of Translational Medicine. 17, 1, 148.

Research output: Contribution to journalArticle

Open Access

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

MITO Investigators, Jun 2019, In : Gynecologic Oncology. 153, 3, p. 535-540 6 p.

Research output: Contribution to journalArticle

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

Pignata, S., Scambia, G., Lorusso, D., De Giorgi, U., Nicoletto, M. O., Lauria, R., Mosconi, A. M., Sacco, C., Omarini, C., Tagliaferri, P., Ferrandina, G., Cinieri, S., Savarese, A., Valabrega, G., Pisano, C., Salutari, V., Raspagliesi, F., Kopf, B., Cecere, S. C., Amadio, G. & 11 others, Maltese, G., Di Napoli, M., Greggi, S., Signoriello, S., Daniele, G., Sacco, A., Losito, S., Normanno, N., Perrone, F., Gallo, C. & Piccirillo, M. C., 2019, In : Gynecologic Oncology. 153, 3, p. 535-540 6 p.

Research output: Contribution to journalArticle

The presence of concomitant mutations affects the activity of egfr tyrosine kinase inhibitors in egfr-mutant non-small cell lung cancer (Nsclc) patients

Rachiglio, A. M., Fenizia, F., Piccirillo, M. C., Galetta, D., Crinò, L., Vincenzi, B., Barletta, E., Pinto, C., Ferraù, F., Lambiase, M., Montanino, A., Roma, C., Ludovini, V., Montagna, E. S., Luca, A. D., Rocco, G., Botti, G., Perrone, F., Morabito, A. & Normanno, N., Mar 10 2019, In : Cancers. 11, 3, 341.

Research output: Contribution to journalArticle

Open Access

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

Rachiglio, A. M., Fenizia, F., Piccirillo, M. C., Galetta, D., Crinò, L., Vincenzi, B., Barletta, E., Pinto, C., Ferraù, F., Lambiase, M., Montanino, A., Roma, C., Ludovini, V., Montagna, E. S., De Luca, A., Rocco, G., Botti, G., Perrone, F., Morabito, A. & Normanno, N., Mar 10 2019, In : Cancers. 11, 3

Research output: Contribution to journalArticle

2018

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cognetti, F., Montemurro, F., Bernardo, A., Gravina, A., Nuzzo, F. & Perrone, F., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M. & 10 others, Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C. & Perrone, F., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2585-2592 8 p.

Research output: Contribution to journalArticle

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M. & 10 others, Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C. & Perrone, F., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2585-2592 8 p.

Research output: Contribution to journalArticle

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M. & 10 others, Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C. & Perrone, F., 2018, In : Journal of Clinical Oncology. 36, 25, p. 2585-2592 8 p.

Research output: Contribution to journalArticle

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016

Marandino, L., La Salvia, A., Sonetto, C., De Luca, E., Pignataro, D., Zichi, C., Di Stefano, R. F., Ghisoni, E., Lombardi, P., Mariniello, A., Reale, M. L., Trevisi, E., Leone, G., Muratori, L., Marcato, M., Bironzo, P., Novello, S., Aglietta, M., Scagliotti, G. V., Perrone, F. & 1 others, Di Maio, M., Dec 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, 12, p. 2288-2295 8 p.

Research output: Contribution to journalArticle

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

Cavalieri, S., Perrone, F., Miceli, R., Ascierto, P. A., Locati, L. D., Bergamini, C., Granata, R., Alfieri, S., Resteghini, C., Galbiati, D., Busico, A., Paielli, N., Patuzzo, R., Maurichi, A., Gallino, G., Ruggeri, R., Mariani, L., Palla, M., Licitra, L. & Bossi, P., Jul 2018, In : European Journal of Cancer. 97, p. 7-15 9 p.

Research output: Contribution to journalArticle

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) & Perrone, F., 2018, In : The Lancet Oncology.

Research output: Contribution to journalArticle

Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study

Chiofalo, M. G., Signoriello, S., Fulciniti, F., Avenia, N., Ristagno, S., Lombardi, C. P., Nicolosi, A., Pelizzo, M. R., Perigli, G., Polistena, A., Panebianco, V., Bellantone, R., Calò, P. G., Boschin, I. M., Badii, B., Di Maio, M., Gallo, C., Perrone, F. & Pezzullo, L., 2018, In : Endocrine. p. 1-8 8 p.

Research output: Contribution to journalArticle

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

Piccirillo, M. C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S. & Perrone, F., May 1 2018, In : Annals of Oncology. 29, 5, p. 1189-1194 6 p.

Research output: Contribution to journalArticle

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

Piccirillo, M. C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S. & Perrone, F., 2018, In : Annals of Oncology. 29, 5, p. 1189-1194 6 p.

Research output: Contribution to journalArticle

2017

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Pan, H., Gray, R., Braybrooke, J., Davies, C., Taylor, C., McGale, P., Peto, R., Pritchard, K. I., Bergh, J., Dowsett, M., Hayes, D. F., EBCTCG & Perrone, F., Nov 9 2017, In : New England Journal of Medicine. 377, 19, p. 1836-1846 11 p.

Research output: Contribution to journalArticle

A case where switching the end points for clinical trial interpretation might be the right choice

Perrone, F., Di Maio, M. & Del Mastro, L., Jun 1 2017, In : JAMA oncology. 3, 6, p. 735-736 2 p.

Research output: Contribution to journalComment/debate

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., Jun 2017, In : Lung Cancer. 108, p. 15-21 7 p.

Research output: Contribution to journalArticle

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Morabito, A., Daniele, G., Costanzo, R., Favaretto, A. G., Filipazzi, V., Rossi, A., Gebbia, V., Castiglione, F., Cavanna, L., Maiello, E., Sandomenico, C., Bonanno, L., Piazza, E., Maione, P., Piccirillo, M. C., Di Maio, M., Rocco, G., Gallo, C., Perrone, F. & Gridelli, C., Jun 1 2017, In : Lung Cancer. 108, p. 15-21 7 p.

Research output: Contribution to journalArticle